Influence of Neoadjuvant Chemotherapy on ER,PR,C-erbB-2,Ki-67 Expressions of Breast Cancer Patients

Jun Zhu

2008-01-01

Abstract:Background and purpose:Neoadjuvant chemotherapy can improve the rates of breast preservation and tumor resection;it is also valuable in assessing the sensitivity of chemotherapy and eliminating the micro-metastasis focus.It is widely used in the therapy of locally advanced breast cancer.The expression of ER,PR,c-erbB-2 and Ki-67 in tumor is very important in terms of determination of operation procedure and the prediction of prognosis of patients.We investigated the impacts of neo-adjuvant chemotherapy on the expression of ER,PR,c-erbB-2 and Ki-67 and on operation procedure and the significance of prognosis.Methods:The expressions of ER,PR,c-erbB-2 and Ki-67 of 40 patients pre-and post-operation were measured.The diagnosis was proved by core biopsy.All the patients took the CEF chemotherapy regimen(CEF).Modified medical operation was performed after two chemotherapy cycles and the ER、PR、c-erbB-2 and Ki-67 expression was measured again.The clinical effect of neoadjuvant chemotherapy was assessed according to the WHO criterion by measuring the size of tumor by physical examination and B type ultrasound.Results:After neo-adjuvant chemotherapy the tumor size shranked in 29 patients,there was no CR or PD to be documented.The expression of ER,PR and c-erbB-2 were no change pre-and post-chemotherapy(P0.05),but Ki-67 expression could be downregulated in 27 patients.Conclusions:Neo-adjuvant chemotherapy can inhibit the tumor growth by downregulation of the expression of Ki-67.